RJR-32521-51915
2 vaccinations
1 coded response
21 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 600 / IL
- Registered
- 2021-07-02
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-07-02
Registered in v-safe
-
2021-07-02
Dose 1 — Pfizer-BioNTech
- 2021-07-02
- 2021-07-03
- 2021-07-05
- 2021-07-06
- 2021-07-07
- 2021-07-08
- 2021-07-09
- 2021-07-16
- 2021-07-23
- 2021-07-30
-
2021-08-02
Dose 2 — Pfizer-BioNTech
- 2021-08-06
- 2021-08-07
- 2021-08-08
- 2021-08-09
- 2021-08-16
-
2021-08-23
Survey response — day 21, dose 2MedDRA: Nasopharyngitis — Feeling: FairFree text: Cold like symptomsMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-30
- 2021-09-06
- 2021-09-13
- 2021-11-01
- 2022-01-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-02 | Pfizer-BioNTech | No |
| 2 | 2021-08-02 | Pfizer-BioNTech | No |
Free text
Release 9 — day 21, dose 2
Symptoms: Cold like symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release